The global Neuroscience market size reached USD 35.9 Billion in 2024 and is expected to grow to USD 48.0 Billion by 2033. The market is projected to expand at a CAGR of 3.1% during the forecast period 2025-2033. Increasing neurological disorders, investments in R&D, advancements in neuroimaging, mental health awareness, and aging populations drive growth. 

Study Assumption Years

• Base Year: 2024
• Historical Year/Period: 2019-2024
• Forecast Year/Period: 2025-2033

Neuroscience Market Key Takeaways

• Current Market Size (2024): USD 35.9 Billion
• CAGR (2025-2033): 3.1%
• Forecast Period: 2025-2033
• Increased funding in research and development efforts by industry players and institutions drives market expansion.
• Rising prevalence of neurological disorders including epilepsy and Alzheimer's boosts demand for treatments.
• Technological advancements in neuroimaging enhance diagnostic and treatment accuracy.
• North America holds the largest market share due to well-established healthcare infrastructure and R&D investments.
• The Asia Pacific region is expected to witness the fastest market growth, driven by rising healthcare spending and initiatives such as China's Brain Project.

Sample Request Link: 

https://www.imarcgroup.com/neuroscience-market/requestsample

Market Growth Factors

Increasing prevalence of neurological disorders such as Alzheimer's disease, Parkinson’s disease, epilepsy, and brain cancer is a major driver for the neuroscience market. For instance, Alzheimer's cases in the US are expected to reach 13 million by 2050. This rising burden, particularly among aging populations, fuels demand for advanced diagnostics and effective therapies, propelling market growth.

Significant investment and funding in neuroscience research and development (R&D) from public institutions, governments, philanthropic organizations, and private enterprises accelerate the pace of scientific discovery. Entities focus on brain mapping, neural data integration, and development of new drugs and technologies. This fosters growth especially in consumables segment with products enhancing neurological care efficiency.

Technological advancements in neuroimaging tools such as MRI, PET, EEG, and emerging neuro-microscopy are enhancing the diagnosis, monitoring, and treatment of neurological disorders. Improvements in imaging resolution, speed, sensitivity, and data analytics facilitate earlier detection and precision treatment planning. Integration of AI and machine learning further boosts diagnostic accuracy across clinical and research applications.

Market Segmentation

Component:

• Instruments and Consumables: This segment dominates due to demand for advanced diagnostic and surgical tools, enhanced efficiency through precision instruments, and increased applications in genomic and proteomic research requiring specialized consumables.
• Software and Services: Complementary to instruments, software and services enable data analysis, management, and advanced research functionalities in neuroscience.

Technology:

• Brain Imaging: Largest market segment driven by demand for accurate and early diagnosis of neurological conditions using MRI, PET, CT, and AI/ML enhanced technologies.
• Neuro-Microscopy: Emerging technology segment focused on ultra-miniature electronic microscopes helping detect and potentially reverse neurological damage.
• Electrophysiology: Technologies involved in measuring electrical activity of the nervous system.
• Neuroproteomic Analysis: Study of proteins related to nervous system function and disorders.
• Animal Behaviour Analysis: Evaluation of animal models for neuroscience research.
• Others: Other neuroscience-related technologies not categorized above.

End User:

• Hospitals: Leading segment due to increasing demand for specialized neurological care, healthcare infrastructure expansion, and advanced treatment technologies.
• Diagnostic Laboratories: Growth driven by need for early, precise disease diagnosis and personalized medicine using advanced diagnostic technologies.
• Research and Academic Institutes: Growth fueled by expanding fundamental and translational research impacting therapy and drug development.
• Others: Includes clinics and ambulatory surgical centers focusing on outpatient and preventive neurological healthcare.

Region:

•  
• North America (United States, Canada)
• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa

Regional Insights

North America dominates the neuroscience market, driven by a high prevalence of chronic and neurological diseases and significant R&D investments. The presence of innovating companies and research institutions sustains growth. For example, CERENOVUS launched the EMBOGUARD catheter in 2022 targeting acute ischemic stroke. Asia Pacific is the fastest-growing region, propelled by increased healthcare spending, infrastructure development, and projects like the China Brain Project with USD 746 Million initial investment.

Recent Developments & News

• In 2021, Blackrock Neurotech developed a wireless brain-computer interface (BCI) system that enables real-time neural activity monitoring without wired connections, enhancing patient comfort during clinical studies.
• In 2022, Kernel introduced Kernel Flow, a non-invasive brain recording device using time-domain functional near-infrared spectroscopy (TD-fNIRS) technology offering high spatial and temporal brain activity resolution, designed for broader clinical and consumer neuroscience research.

Key Players

• Alpha Omega Engineering
• Biobserve GmbH
• Blackrock Neurotech
• Doric Lenses Inc.
• General Electric Company
• Kernel
• Laserglow Technologies
• Mightex Systems
• NeuroNexus Technologies Inc.
• Noldus Information Technology B.V.
• Plexon Inc.
• Prizmatix Ltd.
• Siemens AG

Get Custom Market Research Report for Your Business:

https://www.imarcgroup.com/request?type=report&id=5133&flag=E

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us

IMARC Group,

134 N 4th St. Brooklyn, NY 11249, USA,

Email: sales@imarcgroup.com,

Tel No: (D) +91 120 433 0800,

United States: +1-201971-6302